You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Sanofi’s Rezurock accepted in Scotland

Sanofi has announced that eligible people in Scotland living with chronic graft-versus-host disease (cGVHD) will have access to the company’s Rezurock therapy.